[logo] HealthTree Foundation
more_vert

Crash Course in Cure: Future of Oral Chemotherapy

Crash Course in Cure: Future of Oral Chemotherapy image

Crash Course in Cure: Future of Oral Chemotherapy

Webinar
event May 06, 2026 11:00AM - May 07, 2026 12:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Hear from Dr. Harry Erba as he discusses the future of Oral Chemotherapy in Leukemia Treatment

Schedule & Agenda

The panelist Eliza Prickett
11:00 AM
Introduction
Eliza Prickett

Eliza introduces the agenda of the event and our featured speaker Harry P. Erba, MD, PhD

The panelist Harry P. Erba, MD, PhD
11:05 AM
Presentation
Harry P. Erba, MD, PhD

Dr. Erba talks about oral chemotherapy

The panelist Audience
11:35 AM
Questions and Answers
Audience

Come with your questions and we'll answer them!

Speakers & Moderators

The panelist Eliza Prickett
Eliza Prickett
South Jordan, Utah

Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings. When not in office, Eliza enjoys reading, writing and learning new things about the world.

Read Bio
The panelist Harry P. Erba, MD, PhD
Harry P. Erba, MD, PhD

Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy Director, Leukemia Program, Duke University, Durham, NC Chair, SWOG Leukemia Committee Dr Erba is a professor of medicine in the Division of Hematologic Malignancies and Cellular Therapy at Duke University. He serves as the Director of the Leukemia Program. Dr Erba graduated from Yale University with a Bachelor of Science degree in Biology. He earned his medical degree and doctor of philosophy degree in Biophysics from Stanford University School of Medicine in California. He completed his internship, residency and fellowship at Brigham and Women’s Hospital. He has been a clinical investigator for myeloid neoplasms at the University of Michigan (1996-2012), University of Alabama at Birmingham (2012-2018), and Duke University since 2018. He has served as the Chair of the SWOG Leukemia Committee since 2012, member of the NCI Leukemia Steering Committee since 2012, and the Co-Chair of the Senior Scientific Council of the NCI-sponsored MyeloMATCH precision medicine initiative since 2019.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Together we care.

Together we cure.

100% of every dollar you give supports our life-changing mission.